BiotechTube
Home/Alchemab Therapeutics/Ulrich Wendt
UW

Ulrich Wendt

Chief Business Officer

Alchemab Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesOncology

Alchemab Therapeutics Pipeline

DrugIndicationPhase
ATLX-1282Not specified (focus areas are neurodegeneration/oncology)Phase 1